Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label Phase 4 Study of Etravirine in Antiretroviral-Experienced HIV-1-Infected Subjects
2010-023532-16Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of etravirine in Human immunodeficiency virus infection type 1, sponsored by Janssen Pharmaceutical. Primary endpoint: Safety. Started Oct 2012; status: completed.
02
Drugs
etravirine
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on 2010-023532-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023532-16.